| Nivolumab versus docetaxel in advanced squamous-cell non–small-cell lung cancer J Brahmer, KL Reckamp, P Baas, L Crinò, WEE Eberhardt, ... New England Journal of Medicine 373 (2), 123-135, 2015 | 8920 | 2015 |
| Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ... The Lancet 387 (10027), 1540-1550, 2016 | 6716 | 2016 |
| The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ... Journal of Thoracic Oncology 11 (1), 39-51, 2016 | 4092 | 2016 |
| Photodynamic therapy in oncology M Triesscheijn, P Baas, JHM Schellens, FA Stewart The oncologist 11 (9), 1034-1044, 2006 | 948 | 2006 |
| First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial P Baas, A Scherpereel, AK Nowak, N Fujimoto, S Peters, AS Tsao, ... The Lancet 397 (10272), 375-386, 2021 | 839 | 2021 |
| Effect of pembrolizumab after stereotactic body radiotherapy vs pembrolizumab alone on tumor response in patients with advanced non–small cell lung cancer: results of the … WSME Theelen, HMU Peulen, F Lalezari, V van der Noort, JF De Vries, ... JAMA oncology 5 (9), 1276-1282, 2019 | 785 | 2019 |
| Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma A Scherpereel, P Astoul, P Baas, T Berghmans, H Clayson, P De Vuyst, ... European Respiratory Journal 35 (3), 479-495, 2010 | 770 | 2010 |
| Liquid biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC C Rolfo, PC Mack, GV Scagliotti, P Baas, F Barlesi, TG Bivona, RS Herbst, ... Journal of thoracic oncology 13 (9), 1248-1268, 2018 | 634 | 2018 |
| The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth … WD Travis, H Asamura, AA Bankier, MB Beasley, F Detterbeck, DB Flieder, ... Journal of Thoracic Oncology 11 (8), 1204-1223, 2016 | 630 | 2016 |
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ... Annals of Oncology 25 (8), 1462-1474, 2014 | 545 | 2014 |
| Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 520 | 2016 |
| Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy S Leijen, SA Burgers, P Baas, D Pluim, M Tibben, E van Werkhoven, ... Investigational new drugs 33, 201-214, 2015 | 477 | 2015 |
| The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer K Chansky, FC Detterbeck, AG Nicholson, VW Rusch, E Vallières, ... Journal of Thoracic Oncology 12 (7), 1109-1121, 2017 | 411 | 2017 |
| 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ... Annals of Oncology 26 (8), 1573-1588, 2015 | 407 | 2015 |
| Mesothelioma: Scientific clues for prevention, diagnosis, and therapy M Carbone, PS Adusumilli, HR Alexander Jr, P Baas, F Bardelli, A Bononi, ... CA: a cancer journal for clinicians 69 (5), 402-429, 2019 | 406 | 2019 |
| Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ T Powles, J Bellmunt, E Comperat, M De Santis, R Huddart, Y Loriot, ... Annals of Oncology 33 (3), 244-258, 2022 | 397* | 2022 |
| The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the clinical and pathologic staging of small cell lung … AG Nicholson, K Chansky, J Crowley, R Beyruti, K Kubota, A Turrisi, ... Journal of Thoracic Oncology 11 (3), 300-311, 2016 | 383 | 2016 |
| Photodynamic therapy: a promising new modality for the treatment of cancer JJ Schuitmaker, P Baas, H Van Leengoed, FW Van der Meulen, WM Star, ... Journal of Photochemistry and Photobiology B: Biology 34 (1), 3-12, 1996 | 380 | 1996 |
| Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials WSME Theelen, D Chen, V Verma, BP Hobbs, HMU Peulen, JGJV Aerts, ... The Lancet Respiratory Medicine 9 (5), 467-475, 2021 | 367 | 2021 |
| Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ... Annals of Oncology 25 (9), 1681-1690, 2014 | 363 | 2014 |
